Gå til hovedindhold

Pharmaceutical Supply Security Strategies for a Small Open Economy

Pharmaceutical supply security in a small open economy involves managing structural import dependencies and mitigating systemic global distribution shocks. Resilience is achieved by integrating multi-source procurement, strategic national reserves, and digital authenticity verification across healthcare supply networks. Balancing international trade integration with institutional contingency planning ensures uninterrupted therapeutic availability during geopolitical and macroeconomic crises.

Målet med arbejdet

Examines strategic policy and procurement mechanisms to ensure essential pharmaceutical supply continuity in small open economies subject to global supply shocks.

Metodologi

Comparative qualitative desk-research analyzing peer-reviewed supply chain resilience studies, national health security policy documents, and technological verification models.

Videnskabelig nyhedsværdi

Delineates a tailored resilience architecture combining strategic buffering and digital traceability specifically calibrated for small open economy constraints.

Dokument Forhåndsvisning

Dette er en kort forhåndsvisning. Den fulde version indeholder udvidet tekst til alle sektioner, en konklusion og en formateret bibliografi.

PhD Dissertation

Degree:
Pharmaceutical Supply Security Strategies for a Small Open Economy

Author:

Group

First M. Last

Advisor:

Dr. First Last

City, 2026

Contents

Abstract
Introduction
Chapter 1. Theoretical Foundations of Supply Chain Resilience in Healthcare
1.1 Conceptualizing Vulnerability in Small Open Economy Procurement
1.2 Supply Chain Disruption Mechanisms and Critical Infrastructure Theory
1.3 Multi-Tier Sourcing and Inventory Buffering Dynamics
1.4 Regulatory Governance and International Trade Dependencies
Chapter 2. Methodological Framework for Pharmaceutical Security Assessment
Analysis
2.2 Evaluation Metrics for Supply Criticality and Vulnerability
2.3 Disruption Scenario Mapping and Qualitative Synthesis Protocols
2.4 Methodological Boundaries and Analytical Limitations
Chapter 3. Geopolitical and Exogenous Pressures on Import-Dependent Markets
3.1 Trade Friction, Sanctions, and External Shock Transmission
3.2 Single-Supplier Exposure and Global Active Ingredient Bottlenecks
3.3 Distribution Bottlenecks and Cross-Border Logistics Failures
3.4 Price Sensitivity and National Purchasing Power Asymmetries
Chapter 4. Technological and Institutional Mitigation Mechanisms
4.1 Digital Traceability and Blockchain Verification in Drug Authentication
4.2 Strategic Stockpiling Models and Dynamic National Reserves
4.3 Integrated Health Information Systems and Demand Forecasting
4.4 Public-Private Risk-Sharing Partnerships and Local Formulation Support
Chapter 5. Comparative Strategic Models for Small Open Economies
5.1 Cross-National Policy Responses to Acute Supply Disruption
5.2 Regional Procurement Coalitions versus National Stockpile Autonomy
5.3 Regulatory Flexibility and Accelerated Sourcing Protocols
5.4 Balancing Cost Efficiency with Systemic Redundancy
Chapter 6. Implementation Strategies and Strategic Policy Synthesis
6.1 Multi-Criteria Decision Framework for National Essential Drug Portfolios
6.2 Inter-Agency Coordination and Emergency Response Governance
6.3 Long-Term Resilience Roadmaps for Open Market Environments
Conclusion
Bibliography

Introduction

National healthcare resilience depends fundamentally on the continuous integrity of pharmaceutical supply channels, which operate as critical social and clinical infrastructure [6]. Small open economies face distinctive vulnerabilities within global medicine trade due to high structural import reliance, limited domestic active pharmaceutical ingredient synthesis, and modest purchasing leverage during international supply crunches [1]. Unanticipated global market disruptions, regulatory shifts, and geopolitical tensions rapidly propagate across open borders, exposing healthcare institutions to severe product shortages and quality threats [5]. Establishing robust security mechanisms is therefore essential to prevent operational failure and safeguard public health stability [2].

Traditional procurement frameworks optimized exclusively for cost reduction and just-in-time delivery exhibit severe fragility when confronted with external shocks [2][6]. Small open economies often encounter asymmetric risks, where global manufacturing consolidations and trade restrictions disproportionately diminish domestic access to critical therapeutics [1]. Furthermore, the infiltration of compromised or substandard products during periods of acute deficit introduces compounding threats to clinical safety and regulatory governance [5]. Mitigating these dual challenges requires comprehensive structural realignments that balance economic openness with protective redundancies, technological oversight, and adaptive procurement policies [1][5].

This dissertation evaluates pharmaceutical supply security strategies specifically tailored to the macroeconomic and institutional conditions of a small open economy. Utilizing a comparative qualitative framework grounded in international policy literature, peer-reviewed crisis response evaluations, and technological supply models [1][2][5], the inquiry analyzes the strategic trade-offs between domestic buffer stockpiling, regional joint purchasing alliances, and digital supply verification systems [5][6]. The resulting framework establishes actionable strategic pathways to bolster systemic resilience while preserving the fiscal and trade benefits inherent to open economic systems.

2.3 Disruption Scenario Mapping and Qualitative Synthesis Protocols

Evaluating pharmaceutical supply chain security within small open economies requires a dual-track methodological framework capable of operationalizing both qualitative contingency dynamics and systemic disruption parameters. To capture the multi-dimensional nature of external supply shocks, this dissertation implements a systematic scenario-mapping protocol integrated with qualitative grounded synthesis, establishing rigorous evaluative criteria across strategic, operational, and regulatory tiers. Grounded methodological approaches allow researchers to systematically categorize institutional vulnerabilities and organizational crisis responses across healthcare supply networks without imposing premature structural rigidities (Ebrahimi et al., 2021). By contextualizing qualitative disruption narratives alongside multi-objective disruption management models, the analytical framework identifies critical threshold dependencies where cross-border trade frictions trigger acute product shortages (Rajabi et al., 2024). Furthermore, disruption mapping operationalizes acute stress scenarios—ranging from geopolitical trade restrictions to raw material manufacturing halts—by evaluating how procurement agility and buffer inventories moderate systemic exposure (Sharifi et al., 2021). The synthesis protocol integrates these shock vectors into structured thematic matrices, ensuring that the qualitative categorization of vulnerability remains systematically linked to empirical supply continuity requirements. Consequently, this methodological architecture provides a verifiable foundation for analyzing national resilience capabilities, balancing qualitative institutional assessment with formalized disruption parameters across import-dependent therapeutic categories.

References

  1. Strategies to improve pharmaceutical supply chain resilience under politico-economic sanctions: the case of Iran
    Peivand Bastani, Zahra Dehghan, Seyyed Mansoor Kashfi et al.
    DOI-link
  2. Designing a resilience model for pharmaceutical supply chain during crises: a grounded theory approach
    Peivand Bastani, Omid Sadeghkhani, Ramin Ravangard et al.
    DOI-link
  3. Enhancing Pharmaceutical Supply Chain Resilience: A Multi-Objective Study with Disruption Management
    Oluwadare Abiodun Badejo, Marianthi Ierapetritou
    DOI-link
  4. Enhancing Pharmaceutical Supply Chain Resilience: A Study of Pharmaceutical Companies in Multiple Geographies
    Hima Gupta, Ravindra Asharam Kayande
  5. Enhancing Pharmaceutical Supply Chain Security: Counterfeit Drug Detection Using Blockchain Technology
    Sumit Kumar, Ritika Mehra, Rakesh Arya
  6. Securing the Backbone of Healthcare: Resilience in the Pharmaceutical Supply Chain
    Nicolette Louissaint, Danielle Ekoma
  7. Pharmaceutical Supply Chain
    Fred A. Kuglin
  8. Managing the Pharmaceutical Supply Chain—To Sustainability and Beyond
    Liz Breen, Marina Papalexi, Ying Xie

Tilføj en litteraturliste til opgaven

Verificerede kilderFormateringsstandarderHøj originalitetPro-modeller
Launch Offer -25%

Afhandling

APA 7 (Danish)

24 €31 €
  • 120–180 sider.
  • Høj originalitet
  • Eksport til Word
  • Korrekt formatering
  • Offentlig forhåndsvisning
    En forhåndsvisning af en anden forfatter kan ikke gøres privat. Dit arbejde vil være privat og helt unikt.
  • Litteraturliste (100+, APA 7)
    +1 €
  • Tilføj alternative kilder (Nyheder, .gov, .edu)

Afhandling

APA 7 (Danish)

Pharmaceutical Supply Security Strategies for a Small Open Economy | Afhandling | Aicademy